Search
Migalastat
go.drugbank.com/drugs/DB05018ApprovedInvestigational[L47036,L47057] As of August 2018, migalastat under Amicus Therapeutics' brand name Galafold is currently approved in Australia, Canada, European Union, Israel, Japan, South Korea, Switzerland, and … [L4274] Migalastat (approved and sold under Amicus Therapeutics' brand name Galafold) is subsequently an oral pharmacological chaperone of alpha-Gal A for the treatment of Fabry disease in adults who
Categories: Alpha-Galactosidase A (alpha-Gal A) Pharmacological ChaperonesPiroxicam
go.drugbank.com/drugs/DB00554ApprovedInvestigationalA cyclooxygenase inhibiting, non-steroidal anti-inflammatory agent (NSAID) that is well established in treating rheumatoid arthritis and osteoarthritis and used for musculoskeletal disorders, dysmenorrhea
Products: VERAN-D, PIROXICAM DR. REDDY'SFulvestrant
go.drugbank.com/drugs/DB00947ApprovedInvestigationalFulvestrant is a drug treatment of hormone receptor (HR)-positive metastatic breast cancer in post-menopausal women with disease progression following anti-estrogen therapy.
Products: FULVESTRANT DR. REDDY'SIsopropyl alcohol
go.drugbank.com/drugs/DB02325ApprovedInvestigationalIt is a colorless liquid having disinfectant properties. It is used in the manufacture of acetone and its derivatives and as a solvent. Topically, it is used as an antiseptic.
Mixtures: D-Care 100X, FAK Care4 Bus and School Yellow ORM DCategories: Compounds used in a research, industrial, or household settingOlanzapine
go.drugbank.com/drugs/DB00334ApprovedInvestigational[A176996] Its chemical structure contains a thieno[2,3-b][1,5]benzodiazepine core, and has a methyl group attached to the piperazine ring. … Olanzapine is a thienobenzodiazepine derivative and an atypical or second-generation antipsychotic agent.
Categories: Dopamine D2 Receptor AntagonistsProducts: Olanzapine Glenmark Europe, MARATHON DLopinavir
go.drugbank.com/drugs/DB01601ApprovedInvestigational[L11163] Lopinavir is marketed and administered exclusively in combination with [ritonavir] - this combination, first marketed by Abbott under the brand name Kaletra in 2000, is necessary due to lopinavir's … [saquinavir], [nelfinavir]), lopinavir is a peptidomimetic molecule - it contains a hydroxyethylene scaffold that mimics the peptide linkage typically targeted by the HIV-1 protease enzyme but which itself
Sennosides
go.drugbank.com/drugs/DB11365ApprovedInvestigationalSennosides (also known as senna glycoside or senna) is a medication used to treat constipation[FDA Label][L771] and empty the large intestine before surgery. … It is a weaker laxative than bisacodyl or castor oil[A177092].
Salts: Sennosides A and BMixtures: Laxatif De Sene Et Docusate De SodiumBupropion
go.drugbank.com/drugs/DB01156ApprovedInvestigationalBupropion (also known as the brand name product Wellbutrin®) is a norepinephrine/dopamine-reuptake inhibitor (NDRI) used most commonly for the management of Major Depressive Disorder (MDD), Seasonal Affective … More specifically, bupropion binds to the norepinephrine transporter (NET) and the dopamine transporter (DAT).
Mixtures: Appbutamone-DProducts: ODRANAL® 150 MG TABLETASRECUBIERTAS DE LIBERACION PROLONGADA, BUPROPION 1A PHARMA 150MGDalteparin
go.drugbank.com/drugs/DB06779ApprovedInvestigationalLMWHs have a more predictable response, a greater bioavailability, and a longer anti-Xa half life than unfractionated heparin. Dalteparin can also be safely used in most pregnant women. … Dalteparin, a low molecular weight heparin (LMWH) prepared by nitrous acid degradation of unfractionated heparin of porcine intestinal mucosa origin, is an anticoagulant.
International brands: EurodalProducts: FRAGMIN D, FRAGMIN 2500 U.I/ML (ANTI-XA) VIAL DE 4 MLCabozantinib
go.drugbank.com/drugs/DB08875ApprovedInvestigationalIt was initially approved in the US under the brand name Cometriq, which is indicated for the treatment of metastatic medullary thyroid cancer. … Cabozantinib was first approved in 2012 and is a non-specific tyrosine kinase inhibitor.
Categories: Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index